Pregnancy-associated breast cancer: course, diagnosis and treatment
https://doi.org/10.17749/2313-7347/ob.gyn.rep.2024.563
Abstract
Pregnancy-associated breast cancer (ВС) is a rare pathology in the practice of an obstetrician-gynecologist and oncologist, which diagnostics is coupled to certain difficulties. The joint efforts of specialists to solve this issue taking into account current diagnostic and therapeutic opportunities are aimed at achieving a positive outcome. A clinical case of invasive hormone-dependent ВС T4bN3aM0, IIIC associated with pregnancy presented here is to outline a typical scenario of the following disease course: tumor manifestation in the second trimester, mastitis-like form, late diagnostics. The latter may result from low oncological alertness towards pregnant women under the age of 40 years old due to the rarity of such pathology. The proper decision-making of drug therapy algorithm according to the verified tumor histological variant and immunohistochemical status along with surgical treatment allowed not only to achieve tumor regression, give birth to a healthy full-term baby, but also gave a chance for survival despite late-onset treatment. To avoid advanced disease progression, it is advisable to recommend ultrasound breast examination in the first trimester for pregnant women over 35 years of age.
About the Authors
I. A. SalovRussian Federation
Igor A. Salov, MD, Dr Sci Med, Prof
112 Bolshaya Kazachya Str., Saratov 410012
T. A. Basova
Russian Federation
Tatiana A. Basova, MD, PhD
112 Bolshaya Kazachya Str., Saratov 410012
Yu. V. Mikhailova
Russian Federation
Yuliya V. Mikhailova, MD, PhD
112 Bolshaya Kazachya Str., Saratov 410012
I. I. Frolova
Russian Federation
Iana I. Frolova, MD
112 Bolshaya Kazachya Str., Saratov 410012
References
1. Dashyan G.A., Parokonnaya A.A., Semiglazova T.Yu. Clinical guidelines of the Russian Association of Oncological Mammology. Breast cancer and pregnancy. Moscow, 2016. 17 р. Available at: http://www.breastcancersociety.ru/rek/view/173. [Accessed: 30.08.2024]. (In Russ.).
2. Nikulina L.R., Kuzmichev D.E., Skrebov R.V., Chekashina D.V. Breast cancer associated with pregnancy. [Rak molochnoj zhelezy, associirovannyj s beremennost'yu]. Zdravoohranenie Yugry: opyt i innovacii. 2016;(3):56–61. (In Russ.).
3. Yasenko D.M., Shelkovich S.E. Breast cancer associated with pregnancy. Innovation in medicine and pharmacy-2018: collection of materials of the distance scientific and practical conference of students and young scientists. [Rak molochnoj zhelezy, associirovannyj s beremennost'yu. Innovacii v medicine i farmacii-2018: sbornik materialov distancionnoj nauchno-prakticheskoj konferencii studentov i molodyh uchenyh]. Minsk, 2018. 531–33. (In Russ.).
4. Nadvikova A.D., Vazhenin A.V., Tereshin O.S. et al. Breast cancer associated with pregnancy. [Rak molochnoj zhelezy, associirovannyj s beremennost'yu]. Chelovek. Sport. Medicina. 2016;16(4):27–31. (In Russ.). https://doi.org/10.14529/hsm160403.
5. Clinical guidelines – Breast cancer – 2021-2022-2023 (20.01.2023). [Klinicheskie rekomendacii – Rak molochnoj zhelezy – 2021-2022-2023 (20.01.2023)]. Moscow: Ministerstvo zdravoohraneniya Rossijskoj Federacii, 2023. 94 p. (In Russ.). Available at: http://disuria.ru/_ld/12/1279_kr21D05C50MZ.pdf. [Accessed: 30.08.2024].
6. Tyulyandin S.A., Artamonova E.V., Zhukova L.G. et al. Practical recommendations for the drug treatment of breast cancer. [Prakticheskie rekomendacii po lekarstvennomu lecheniyu raka molochnoj zhelezy]. Zlokachestvennye opuholi. 2022;12(3S2–1):155–97. (In Russ.). https://doi.org/10.18027/2224-5057-2022-12-3s2-155-197.
7. Vladimirova L.Yu., Gladkov O.A., Koroleva I.A. et al. Practical recommendations for the prevention and treatment of nausea and vomiting in cancer patients. [Prakticheskie rekomendacii po profilaktike i lecheniyu toshnoty i rvoty u onkologicheskih bol'nyh]. Zlokachestvennye opuholi. 2021;11(3s2–2):25–38. (In Russ.). https://doi.org/10.18027/2224-5057-2021-11-3s2-37.
8. Sakaeva D.D., Borisov K.E., Bulavina I.S. et al. Practical recommendations for the diagnosis and treatment of febrile neutropenia. [Prakticheskie rekomendacii po diagnostike i lecheniyu febril'noj nejtropenii]. Zlokachestvennye opuholi. 2022;12(3s2–2):55–63. (In Russ.). https://doi.org/10.18027/2224-5057-2022-12-3s2-55-63.
9. Clinical guidelines – Venous complications during pregnancy and the postpartum period. Obstetric thromboembolism. [Klinicheskie rekomendacii – Venoznye oslozhneniya vo vremya beremennosti i poslerodovom periode. Akusherskaya tromboemboliya – 2022-2023-2024 (14.02.2022)]. Moscow: Ministerstvo zdravoohraneniya Rossijskoj Federacii, 2022. 66 p. (In Russ.). Available at: https://phlebology-sro.ru/upload/iblock/72a/vteo-vo-vremya-beremennosti-i-poslerodovom-periode-2022.pdf. [Accessed: 30.08.2024].
10. Order of the Ministry of Health and Social Development of the Russian Federation of 03.12.2007 N 736 "On approval of the list of medical indications for artificial termination of pregnancy". [Prikaz Minzdravsocrazvitiya RF ot 03.12.2007 N 736 «Ob utverzhdenii perechnya medicinskih pokazanij dlya iskusstvennogo preryvaniya beremennosti»]. Moscow, 2007. (In Russ.). Available at: https://legalacts.ru/doc/prikaz-minzdravsotsrazvitija-rf-ot-03122007-n-736/. [Accessed: 30.08.2024].
11. Coates A.S., Winer E.P., Goldhirsch A. et al. Tailoring therapies–improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. Ann Oncol. 2015;26(8):1533–46. https://doi.org/10.1093/annonc/mdv221
12. Gradishar W.J., Anderson B.O., Abraham J. et al. Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020;18(4):452–78. https://doi.org/10.6004/jnccn.2020.0016.
13. State of oncological care for the population of Russia in 2022. Eds. A.D. Kaprin, V.V. Starinskiy, A.O. Shakhzadova. [Sostoyanie onkologicheskoj pomoshchi naseleniyu Rossii v 2022 godu. Pod red. A.D. Kaprina, V.V. Starinskogo, A.O. Shahzadovoj]. Moscow, 2023. 254 p. (In Russ.). Available at: https://oncology-association.ru/wp-content/uploads/2023/08/sop-2022-el.versiya_compressed.pdf. [Accessed: 30.08.2024].
What is already known about this subject?
► Breast cancer (ВС) in pregnant women is a rare pathology in practice of an obstetrician-gynecologist and the most common among oncopathology in pregnant women.
► ВС is not an indication for pregnancy termination.
► Current therapy interventions allow to successfully treat BC provided that pregnancy is prolonged by giving a chance for survival and a joy of motherhood.
What are the new findings?
► The article is intended to draw an obstetrician-gynecologist’s attention providing primary outpatient health care to ВС issue in pregnant women.
► The clinical case described additionally confirms a promise of treating ВС and maintaining pregnancy.
How might it impact on clinical practice in the foreseeable future?
► Knowing such clinical case will increase cancer awareness regarding > 35 year-old pregnant women with cancer risk factors such as ВC in first-second-lineage female relatives, late childbirth.
► Mandatory and thorough breast examination in pregnant women upon registration, ultrasound examination at the end of the first pregnancy trimester will allow to timely suspect cancer, correctly design and implement an algorithm of therapeutic diagnostic measures to achieve a favorable outcome.
Review
For citations:
Salov I.A., Basova T.A., Mikhailova Yu.V., Frolova I.I. Pregnancy-associated breast cancer: course, diagnosis and treatment. Obstetrics, Gynecology and Reproduction. 2024;18(5):754–760. (In Russ.) https://doi.org/10.17749/2313-7347/ob.gyn.rep.2024.563

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.